These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6548211

  • 1. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
    Adams GE, Ahmed I, Sheldon PW, Stratford IJ.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
    [Abstract] [Full Text] [Related]

  • 2. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
    Adams GE, Ahmed I, Sheldon PW, Stratford IJ.
    Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
    [Abstract] [Full Text] [Related]

  • 3. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
    Ahmed I, Jenkins TC, Walling JM, Stratford IJ, Sheldon PW, Adams GE, Fielden EM.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
    [Abstract] [Full Text] [Related]

  • 4. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
    Walling JM, Stratford IJ, Adams GE, Silver AR, Ahmed I, Jenkins TC, Fielden EM.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
    [Abstract] [Full Text] [Related]

  • 5. The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumor.
    Chaplin DJ, Durand RE, Stratford IJ, Jenkins TC.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1091-5. PubMed ID: 3755714
    [Abstract] [Full Text] [Related]

  • 6. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
    Austen KR, Jenner TJ, O'Neill P, Fielden EM.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
    [Abstract] [Full Text] [Related]

  • 7. Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.
    Stratford IJ, Adams GE, Godden J, Howells N.
    Int J Radiat Biol; 1989 Mar; 55(3):411-22. PubMed ID: 2564037
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW, Maddison K, Wolf K.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [Abstract] [Full Text] [Related]

  • 9. Comparative DNA damage and repair induced by misonidazole, CB 1954 and RSU 1069.
    Dale LD, Widdick DA, Edwards DI, Biol GI.
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):995-9. PubMed ID: 2649469
    [Abstract] [Full Text] [Related]

  • 10. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
    Hill RP, Gulyas S, Whitmore GF.
    Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of DNA damage in mammalian cells upon bioreduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131.
    Jenner TJ, Sapora O, O'Neill P, Fielden EM.
    Biochem Pharmacol; 1988 Oct 15; 37(20):3837-42. PubMed ID: 3190731
    [Abstract] [Full Text] [Related]

  • 12. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    Siemann DW.
    Int J Radiat Oncol Biol Phys; 1989 Apr 15; 16(4):1115-8. PubMed ID: 2703392
    [Abstract] [Full Text] [Related]

  • 13. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S, Stratford IJ, Adams GE, Fielden EM, Jenkins TC.
    Radiat Res; 1990 Oct 15; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069.
    Workman P, Walton MI.
    Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1307-10. PubMed ID: 6547936
    [Abstract] [Full Text] [Related]

  • 18. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
    Jenner TJ, O'Neill P, Crump PW, Fielden EM, Sapora O, Santodonato L.
    Biochem Pharmacol; 1991 Oct 09; 42(9):1705-10. PubMed ID: 1930296
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo radiosensitizing effects of 2-nitroimidazole derivatives with sugar component.
    Murayama C, Tanaka N, Miyamoto Y, Sakaguchi M, Mori T.
    Strahlenther Onkol; 1987 Jun 09; 163(6):385-90. PubMed ID: 3603366
    [Abstract] [Full Text] [Related]

  • 20. The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
    Stratford IJ, Walling JM, Silver AR.
    Br J Cancer; 1986 Mar 09; 53(3):339-44. PubMed ID: 3754453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.